The development of new classes of antiretroviral drugs, such as integrase inhibitors and CCR5-antagonistic entry inhibitors, has opened the possibility of considering regimens without NRTIs (Table 1).

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to treat HIV and hepatitis B. Along with their antiretroviral effects, drugs ...

An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved ...